Bio-Rad Laboratories | BIO - Sales Revenues

Stock Price
299.88
Daily Change
-6.02 -1.97%
Monthly
-7.87%
Yearly
-13.33%
Q1 Forecast
284.65

Bio-Rad Laboratories reported $653M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
Agilent USD 1.86B 123M Sep/2025
Becton, Dickinson and Co. USD 5.9B 400M Sep/2025
Bio Techne USD 295.9M 9.34M Dec/2025
Bio-Rad Laboratories USD 653M 1.4M Sep/2025
Bruker USD 860.5M 63.1M Sep/2025
Charles River Laboratories USD 1000M 32.14M Sep/2025
Danaher USD 6.84B 790M Dec/2025
Exact Sciences USD 851M 39.9M Sep/2025
General Electric Aerospace USD 11.87B 560M Dec/2025
Hologic USD 1.05B 0 Dec/2025
Illumina USD 1.08B 20M Sep/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Laboratory Of America USD 3.56B 30M Sep/2025
Merck USD 16.4B 880M Dec/2025
Mettler Toledo International USD 1.03B 46.78M Sep/2025
Myriad Genetics USD 205.7M 7.4M Sep/2025
Quest Diagnostics USD 2.82B 60M Sep/2025
Repligen USD 189M 7M Sep/2025
Revvity USD 772.06M 73.06M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Siemens EUR 21.43B 2.05B Sep/2025
Standard Biotools USD 19.55M 2.21M Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Tosoh JPY 256.94B 2.93B Dec/2025
Waters USD 800M 29M Sep/2025